Analytic validation and clinical utilization of the comprehensive genomic profiling test, GEM ExTra(®)

We developed and analytically validated a comprehensive genomic profiling (CGP) assay, GEM ExTra, for patients with advanced solid tumors that uses Next Generation Sequencing (NGS) to characterize whole exomes employing a paired tumor-normal subtraction methodology. The assay detects single nucleoti...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Tracey, Szelinger, Szabolcs, LoBello, Janine, King, Amy, Aldrich, Jessica, Garinger, Nathan, Halbert, Matthew, Richholt, Ryan F., Mastrian, Stephen D., Babb, Cody, Ozols, Audrey A., Goodman, Laurie J., Basu, Gargi D., Royce, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057276/
https://www.ncbi.nlm.nih.gov/pubmed/33889297
http://dx.doi.org/10.18632/oncotarget.27945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057276/
https://www.ncbi.nlm.nih.gov/pubmed/33889297
http://dx.doi.org/10.18632/oncotarget.27945

Ejemplares similares